Physician profile
Robert L Bennett
NPI 1538189501
$2,349.31
in general payments reported to CMS, 2019-2025
26 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $387 · 2021: $356 · 2022: $251 · 2023: $335 · 2024: $193 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $340.27 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $230.28 | 2019-2025 | Mounjaro, Jardiance |
| Amarin Pharma, INC. | $221.61 | 2019-2021 | |
| Glaxosmithkline, LLC. | $216.00 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.21 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $176.23 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $155.56 | 2019-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $149.31 | 2019-2022 | |
| Abbott Laboratories | $98.35 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Baxter Healthcare | $61.74 | 2023 | Hillrom - Life 2000 Ventilation System |
| Esperion Therapeutics, INC. | $60.28 | 2021-2023 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $58.05 | 2022 | |
| Abiomed | $53.01 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $40.66 | 2021-2022 | |
| Medtronic, INC. | $39.70 | 2021-2025 | Azure Xt Dr Mri Surescan |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.06 | 2023 | Xarelto |
| Viiv Healthcare Company | $28.99 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $26.82 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.94 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.50 | 2023 | Linzess |
| Exact Sciences Corporation | $21.98 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $19.25 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.67 | 2022 | |
| Sanofi Pasteur INC. | $16.28 | 2019 | |
| Dexcom, INC. | $16.12 | 2024 | Dexcom G6 Transmitter |
| Medtronic USA, INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.